Implementation of a PMTCT programme in a high HIV prevalence setting in Johannesburg, South Africa: 2002-2015.
PMTCT
South Africa
health systems
paediatric HIV infection
pregnant women living with HIV (PWLHIV)
Journal
Southern African journal of HIV medicine
ISSN: 2078-6751
Titre abrégé: South Afr J HIV Med
Pays: South Africa
ID NLM: 100965417
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
08
2019
accepted:
20
10
2019
entrez:
15
4
2020
pubmed:
15
4
2020
medline:
15
4
2020
Statut:
epublish
Résumé
Great strides have been made in decreasing paediatric human immunodeficiency virus (HIV) infections, especially in sub-Saharan Africa. In South Africa, new paediatric HIV infections decreased by 84% between 2009 and 2015. This achievement is a result of a strong political will and the rapid evolution of the country's prevention of mother-to-child transmission (PMTCT) guidelines. In this paper we report on the implementation of a large PMTCT programme in Soweto, South Africa. We reviewed routinely collected PMTCT data from 13 healthcare facilities, for the period 2002-2015. Antiretroviral therapy (ART) coverage among pregnant women living with HIV (PWLHIV) and the mother-to-child transmission (MTCT) rate at early infant diagnosis were evaluated. In total, 360 751 pregnant women attended the facilities during the review period, and the HIV prevalence remained high throughout at around 30%. The proportion of PWLHIV presenting with a known HIV status increased from 14.3% in 2009 when the indicator was first collected to 45% in 2015, The achievements in decreasing paediatric HIV infections have been hailed as one of the greatest public health achievements of our times. While there are inherent limitations with using routinely collected aggregate data, the Soweto data reflect progress made in the implementation of PMTCT programmes in South Africa. Progress with PMTCT has, however, not been accompanied by a decline in HIV prevalence among pregnant women.
Sections du résumé
BACKGROUND
BACKGROUND
Great strides have been made in decreasing paediatric human immunodeficiency virus (HIV) infections, especially in sub-Saharan Africa. In South Africa, new paediatric HIV infections decreased by 84% between 2009 and 2015. This achievement is a result of a strong political will and the rapid evolution of the country's prevention of mother-to-child transmission (PMTCT) guidelines.
OBJECTIVES
OBJECTIVE
In this paper we report on the implementation of a large PMTCT programme in Soweto, South Africa.
METHODS
METHODS
We reviewed routinely collected PMTCT data from 13 healthcare facilities, for the period 2002-2015. Antiretroviral therapy (ART) coverage among pregnant women living with HIV (PWLHIV) and the mother-to-child transmission (MTCT) rate at early infant diagnosis were evaluated.
RESULTS
RESULTS
In total, 360 751 pregnant women attended the facilities during the review period, and the HIV prevalence remained high throughout at around 30%. The proportion of PWLHIV presenting with a known HIV status increased from 14.3% in 2009 when the indicator was first collected to 45% in 2015,
CONCLUSION
CONCLUSIONS
The achievements in decreasing paediatric HIV infections have been hailed as one of the greatest public health achievements of our times. While there are inherent limitations with using routinely collected aggregate data, the Soweto data reflect progress made in the implementation of PMTCT programmes in South Africa. Progress with PMTCT has, however, not been accompanied by a decline in HIV prevalence among pregnant women.
Identifiants
pubmed: 32284888
doi: 10.4102/sajhivmed.v21i1.1024
pii: HIVMED-21-1024
pmc: PMC7136691
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1024Informations de copyright
© 2020. The Authors.
Déclaration de conflit d'intérêts
The authors have declared that no competing interest exists.
Références
J Glob Health. 2017 Jun;7(1):010701
pubmed: 28567281
Bull World Health Organ. 2013 Jan 1;91(1):70-4
pubmed: 23397353
Lancet Infect Dis. 2016 Jun;16(6):e92-e107
pubmed: 27049574
S Afr Med J. 2014 Mar;104(3 Suppl 1):239-43
pubmed: 24893500
S Afr Med J. 2010 Mar 30;100(4):210-2
pubmed: 20459957
Obstet Med. 2015 Mar;8(1):5-12
pubmed: 27512452
S Afr Med J. 2014 Mar;104(3 Suppl 1):249-51
pubmed: 24893502
Lancet. 2002 Apr 6;359(9313):1178-86
pubmed: 11955535
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e77-83
pubmed: 25585302
PLoS One. 2013 May 16;8(5):e63328
pubmed: 23696814
N Engl J Med. 2013 Oct 10;369(15):1385-7
pubmed: 24106930
J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):247-50
pubmed: 24346642
J Glob Health. 2016 Dec;6(2):020405
pubmed: 27698999
AIDS. 2014 Apr 24;28(7):1049-57
pubmed: 24566097
AIDS. 2005 Aug 12;19(12):1289-97
pubmed: 16052084
N Engl J Med. 2016 Feb 25;374(8):761-70
pubmed: 26933850
BMC Infect Dis. 2015 Aug 12;15:328
pubmed: 26265222
J Infect Dis. 2003 Mar 1;187(5):725-35
pubmed: 12599045
AIDS. 2010 Jan 2;24(1):85-91
pubmed: 19809271
J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):e170-8
pubmed: 24759066
Int J Med Inform. 2016 Nov;95:60-70
pubmed: 27697233
AIDS. 2012 Nov 28;26(18):2361-73
pubmed: 22948267